IIM
IRWD icon

INTECH Investment Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

INTECH Investment Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$137K Sell
39,043
-32,530
-45% -$133K ﹤0.01% 1836
2025
Q4 		$241K Sell
71,573
-621
-0.9% -$1.61K ﹤0.01% 1874
2025
Q3 		$94.6K Sell
72,194
-15,593
-18% -$16.1K ﹤0.01% 2283
2025
Q2 		$63K Hold
87,787
– – ﹤0.01% 2391
2025
Q1 		$129K Buy
87,787
+30,543
+53% +$72.7K ﹤0.01% 2248
2024
Q4 		$254K Buy
57,244
+13,205
+30% +$53.6K ﹤0.01% 1918
2024
Q3 		$181K Buy
+44,039
New +$237K ﹤0.01% 1758

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

INTECH Investment Management's IRWD Position: Q1 2026 in Review

INTECH Investment Management reduced its Ironwood Pharmaceuticals (IRWD) stake by 45% in Q1 2026, selling an estimated $133K and leaving 39,043 shares worth $137K. The position accounts for ﹤0.01% of the portfolio, ranked #1836.

INTECH Investment Management first reported a position in IRWD in Q3 2024 and has held it in 7 quarters since. The position peaked at $254K in Q4 2024. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • INTECH Investment Management held 39,043 shares of Ironwood Pharmaceuticals worth $137K as of Q1 2026.
  • INTECH Investment Management sold 32,530 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $133K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of INTECH Investment Management's portfolio in Q1 2026, its #1836 holding.
  • INTECH Investment Management first reported a position in Ironwood Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • INTECH Investment Management's Ironwood Pharmaceuticals position peaked at $254K in Q4 2024.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.